XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 750,334 $ 666,732 $ 2,185,938 $ 1,935,104
Salaries, wages and benefits (including equity-based compensation expense of $8,163, $7,240, $23,140 and $21,745, respectively) 394,150 352,582 1,171,960 1,027,732
Professional fees 45,540 40,367 130,468 117,718
Supplies 27,147 25,570 79,312 74,291
Rents and leases 11,731 11,339 34,880 33,780
Other operating expenses 104,048 88,993 290,798 255,355
Income from provider relief fund (4,442) (7,656) (4,442) (16,206)
Depreciation and amortization 33,388 29,573 96,969 87,627
Interest expense, net 20,742 18,003 61,651 50,355
Legal settlements expense 394,181   394,181  
Loss on impairment     8,694  
Transaction-related expenses 11,247 10,859 26,792 18,381
Total expenses 1,037,732 569,630 2,291,263 1,649,033
(Loss) income before income taxes (287,398) 97,102 (105,325) 286,071
(Benefit from) provision for income taxes (71,873) 24,056 (29,907) 69,183
Net (loss) income (215,525) 73,046 (75,418) 216,888
Net income attributable to noncontrolling interests (2,185) (1,947) (3,978) (4,873)
Net (loss) income attributable to Acadia Healthcare Company, Inc. $ (217,710) $ 71,099 $ (79,396) $ 212,015
(Loss) earnings per share attributable to Acadia Healthcare Company, Inc. stockholders:        
Basic $ (2.39) $ 0.79 $ (0.87) $ 2.37
Diluted $ (2.39) $ 0.78 $ (0.87) $ 2.31
Weighted-average shares outstanding:        
Basic 91,168 89,833 90,852 89,607
Diluted 91,168 91,723 90,852 91,668